Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Conference Call and Webcast Scheduled for May 13, 2026 at 2 p.m. PT/5 p.m. ET SOUTH SAN FRANCISCO, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a...
-
AGOURA HILLS, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- via IBN -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC) (“Oncotelic” or the “Company”), a late-stage clinical biopharmaceutical company focused...
-
Gigamon released its 2026 Hybrid Cloud Security Survey, revealing AI’s impact on the shifting cyber threat landscape as attackers outpace defenders.
-
Hantavirus Cluster Linked to Cruise Ship Highlights Ongoing Zoonotic Risk and the Need for Vigilance
For hantavirus cluster, experts emphasize caution while underscoring the importance of environmental controls, early detection, and clear communication.
-
Causal Dynamics Lab flagship product Cielara Code beat both Claude Code (Opus-4.6) and OpenAI Codex (GPT-5.4).
-
Series A financing led by 4BIO Capital, with major new investors Servier Ventures, Sound Bioventures, British Business Bank and Criteria Bio Ventures, supported by existing investors Abingworth and...
-
This research investment will enable Dr. Jeanette Boudreau to prepare powerful natural killer cell immunotherapy to move into clinical trials
-
Oncolytics announced new data in metastatic colorectal cancer, demonstrating 3-4x improvement in duration response vs. historical 4-6 month benchmark.
-
Jeremy B. Fitch, MBA, appointed as Chief Business OfficerMichael A. Alrutz, J.D., Ph.D., appointed as General CounselGuy C. Ruble, PharmD, appointed as VP, Regulatory Affairs CAMBRIDGE, United...
-
Toronto, Ontario, May 04, 2026 (GLOBE NEWSWIRE) -- Dr. Roger Wong has been selected as the 2026 recipient of the Award for Eminent Contribution to Older Adults in Canada. He will be honoured by the...